Farringdon Capital’s ResMed RMD Stock Holding History

Farringdon Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,343	Closed	-$323K	–	559
2025 Q4	$323K	Buy	+1,343	New	+$343K	0.08%	307
2025 Q1	–	Sell	-2,965	Closed	-$678K	–	568
2024 Q4	$678K	Buy	+2,965	New	+$714K	0.28%	89

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Farringdon Capital's RMD Position: Q1 2026 in Review

Farringdon Capital sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,343 shares — an estimated $323K sold.

Farringdon Capital first reported a position in RMD in Q4 2024 and held it in 2 quarters. The position peaked at $678K in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Farringdon Capital reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Farringdon Capital sold 1,343 ResMed shares in Q1 2026, an estimated $323K.
Farringdon Capital first reported a position in ResMed in Q4 2024 and held it in 2 quarters.
Farringdon Capital's ResMed position peaked at $678K in Q4 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.